Roger Sidhu serves as Executive at Brooklyn ImmunoTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Roger Sidhu has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 20, 2022 involved exercising options for 20,163 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 20, 2022 | BTX | $0 | Option Exercise | 20,163 | $N/A | Discretionary |
Roger Sidhu currently holds 20,163 shares of Brooklyn ImmunoTherapeutics, Inc. (BTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger Sidhu has been a net neutral trader of BTX stock. They have purchased $0 and sold $0 worth of shares.
Roger Sidhu's most recent insider trade was on Sep 20, 2022, when they sold 20,163 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted